Biomarkers for ovarian cancer : new technologies and targets to address persistently unmet needs / guest-editors: Michael A. Tainsky and Anna Lokshin.
Material type: TextSeries: Cancer biomarkers ; Vol. 8, nos. 4-5.Publisher: Amsterdam : IOS Press, [2011]Copyright date: ©2011Description: 161-307 pages : illustrations ; 26 cmContent type:- text
- unmediated
- volume
- 1607509784
- 9781607509783
- 616.99465 23
Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Book | North Campus North Campus Main Collection | 616.99465 BIO (Browse shelf(Opens below)) | 1 | Available | A483722B |
Includes bibliographical references.
FDG-PET /CT as a molecular biomarker in ovarian cancer / Ewa Nowosinska, Stefanie Avril, Iain Murray, Teresa Szyszko and Norbert Avril -- Screening for ovarian cancer: Old tools, new lessons / Brian M. Nolen and Anna E. Lokshin -- Autoantibodies as biomarkers for ovarian cancer / Madhumita Chatterjee and Michael A. Tainsky -- The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer / Curtis Balch and Kenneth P. Nephew -- Searching for a system: The quest for ovarian cancer biomarkers / Karin D. Rodland and Nita J. Maihle -- Prognostic biomarkers in ovarian cancer / Jie Huang, Wei Hu and Anil K. Sood -- Tumor vascular biomarkers: New opportunities for cancer diagnostics / Chunsheng Li, Dimitra Sasaroli, Xiang Chen, Jia Hu, Raphael Sandaltzopoulos, Yadolah Omidi and George Coukos -- Glycomic analysis of ovarian cancer: Past, present, and futureAuthorKaren L. AbbottTumor-derived exosomes as mediators of disease and potential diagnostic biomarkers / Carolyn D. Roberson, Safinur Atay, Cicek Gercel-Taylor and Douglas D. Taylor.
Machine converted from non-AACR2, non-ISBD source record.
There are no comments on this title.